Poland's pharma market continues to grow
This article was originally published in Scrip
Executive Summary
Poland's domestic drug manufacturers are more positive about the current state of the national pharmaceutical market than companies with a substantial foreign equity stakes. Two thirds of the former assessed the market as good compared with less than half of the latter.